SMARCB1 was first confirmed as a potent in vivo tumor suppressor when a conditional gene knockout of Smarcb1 led to fully penetrant cancer formation in adult mice, resulting in CD8+ mature lymphoma [26]. Here, SMARCB1 is linked to cancer.